Mid-Day Market Update: Crude Oil Down 2%; Synlogic Shares Spike Higher
Midway through trading Monday, the Dow traded down 1.51% to 34,063.71 while the NASDAQ fell 2.13% to 14,723.20. The S&P also fell, dropping 1.64% to 4,360.41.
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday.
Mid-Morning Market Update: Markets Open Lower; Brooks Automation Divests Semiconductor Business For $3B
Following the market opening Monday, the Dow traded down 1.42% to 34,093.46 while the NASDAQ fell 1.86% to 14,763.93. The S&P also fell, dropping 1.54% to 4,364.65.
HC Wainwright & Co. Maintains Buy on Protagonist Therapeutics, Lowers Price Target to $50
HC Wainwright & Co. analyst Douglas Tsao maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and lowers the price target from $60 to $50.
SVB Leerink Maintains Outperform on Protagonist Therapeutics, Lowers Price Target to $35
SVB Leerink analyst Joseph Schwartz maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Outperform and lowers the price target from $50 to $35.
JP Morgan Downgrades Protagonist Therapeutics to Neutral, Announces $49 Price Target
JP Morgan analyst Anupam Rama downgrades Protagonist Therapeutics (NASDAQ:PTGX) from Overweight to Neutral and announces $49 price target.
48 Biggest Movers From Friday
Gainers
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.
Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet
Toward the end of trading Friday, the Dow traded down 0.47% to 4,587.22 while the NASDAQ fell 1.05% to 15,023.11. The S&P also fell, dropping 0.85% to 4,435.65.